AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership3,284 shares
Latest Disclosed Value $ 609,576
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 4.76% decrease in ownership of ABBV / AbbVie Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 3,284 shares of AbbVie Inc. (US:ABBV) valued at $609,576 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 3,448 shares of AbbVie Inc.. This represents a change in shares of -4.76% during the quarter. The current value of the position is $738,703 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP AbbVie EC US00287Y1091 3,284 -164 -4.76 610 -15.65 6.7746
2025-05-29 2025-03-31 NP AbbVie EC US00287Y1091 3,448 -1,122 -24.55 722 -11.08 7.6745
2025-03-03 2024-12-31 NP AbbVie EC US00287Y1091 4,570 -336 -6.85 812 -16.12 8.1412
2024-11-29 2024-09-30 NP AbbVie EC US00287Y1091 4,906 -389 -7.35 969 6.61 8.7752
2024-08-29 2024-06-30 NP AbbVie EC US00287Y1091 5,295 -625 -10.56 908 -15.77 8.2798
2024-05-30 2024-03-31 NP AbbVie EC US00287Y1091 5,920 -213 -3.47 1,078 13.47 9.1424
2024-02-29 2023-12-31 NP AbbVie EC US00287Y1091 6,133 -668 -9.82 950 -6.22 7.7898
2023-11-29 2023-09-30 NP AbbVie EC US00287Y1091 6,801 -625 -8.42 1,014 1.30 8.7773
2023-08-28 2023-06-30 NP AbbVie EC US00287Y1091 7,426 252 3.51 1,001 -12.51 7.8955
2023-05-30 2023-03-31 NP AbbVie EC US00287Y1091 7,174 -1,421 -16.53 1,143 -17.71 8.6599
2023-02-28 2022-12-31 NP AbbVie EC US00287Y1091 8,595 21 0.24 1,389 20.78 8.4002
2022-11-29 2022-09-30 NP AbbVie EC US00287Y1091 8,574 414 5.07 1,151 -7.93 8.0304
2022-08-29 2022-06-30 NP AbbVie EC US00287Y1091 8,160 -752 -8.44 1,250 -13.50 8.5741
2022-05-26 2022-03-31 NP AbbVie EC US00287Y1091 8,912 -2,929 -24.74 1,445 -9.92 8.5369
2022-02-28 2021-12-31 NP AbbVie EC US00287Y1091 11,841 113 0.96 1,603 26.72 7.0846
2021-11-29 2021-09-30 NP AbbVie EC US00287Y1091 11,728 -33 -0.28 1,265 -4.46 5.3182
2021-08-27 2021-06-30 NP AbbVie EC US00287Y1091 11,761 -1,027 -8.03 1,325 -4.27 5.5484
2021-05-27 2021-03-31 NP AbbVie EC US00287Y1091 12,788 -2,347 -15.51 1,384 -14.68 6.2273
2021-03-01 2020-12-31 NP AbbVie EC US00287Y1091 15,135 -3,965 -20.76 1,622 -3.05 6.6045
2020-11-25 2020-09-30 NP AbbVie EC US00287Y1091 19,100 571 3.08 1,673 -8.08 6.9825
2020-08-27 2020-06-30 NP AbbVie EC US00287Y1091 18,529 1,695 10.07 1,819 41.89 7.3313
2020-06-01 2020-03-31 NP AbbVie EC US00287Y1091 16,834 -1,073 -5.99 1,283 -19.12 7.8505
2020-03-02 2019-12-31 NP AbbVie EC US00287Y1091 17,907 -774 -4.14 1,585 12.09 7.3388
2019-11-27 2019-09-30 NP AbbVie EC US00287Y1091 18,681 18,681 1,415 7.5042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.